Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis
Background: Myasthenic crisis (MC) is a potentially life-threatening complication of myasthenia gravis. Its precipitating factors include surgical procedures, particularly thymectomy. The role of preoperative intravenous immunoglobulin (IVIg) in preventing MC in patients scheduled for thymectomy and...
Main Authors: | Josep Gamez, María Salvadó, Francesc Carmona, Miriam de Nadal, Laura Romero, Daniel Ruiz, Alberto Jáuregui, Olga Martínez, Javier Pérez, Pilar Suñé, María Deu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286419864497 |
Similar Items
-
Effect of Thymectomy in Myasthenia Gravis
by: Tuncay Gündüz
Published: (2016-12-01) -
The role of thymectomy in myasthenia gravis: A programmatic approach to thymectomy and perioperative management of myasthenia gravis
by: Ahmed AL-Bulushi, et al.
Published: (2021-06-01) -
Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: A 17-year experience
by: Shalmani Hamidreza, et al.
Published: (2004-09-01) -
The clinical outcome of thymectomy in myasthenia gravis
by: Mirsharifi R, et al.
Published: (2009-02-01) -
Myasthenia gravis and myasthenic syndromes
by: Vincent, A
Published: (2007)